Development of Tissue Engineering for Urologic Conditions: An Overview

Introduction

Damage to the tissues and loss of the organs caused by degenerative illnesses or neoplasia continue to be challenging to cure. The most acceptable procedures for repairing damaged tissues include a variety of treatments that are fraught with complications. Transplantation techniques are used to treat end-stage organ failure. In general, the outcomes are disappointing regarding immunosuppressive issues, an excess of failing organs, and a decline in donor numbers. As a result, an alternate method for replacing or repairing the destroyed organs and tissues was required. Consequently, regenerative medicine and tissue engineering (TE) evolved to understand tissue regeneration mechanics and discover a technique to restore injured tissues. The end-organ function can be restored by improving tissue regeneration or generating biological tissue replacements that accommodate lost function.

What Are The Basic Principles Of Tissue Engineering?

1. Tissue Engineering Approaches

• The acellular method comprises natural or synthetic matrices, commonly called scaffolds, to promote the body's natural capacity to heal independently and aid in assessing new tissue development direction.

• Scaffolds with a high collagen content decay gradually and are eventually replaced by a host extracellular matrix rich in in-growing cells. Scaffolds can also be obtained from different autologous, allogeneic, or xenogeneic tissues and treated chemically and mechanically to eliminate biological components before implantation.

• The cellular technique concept employs donor cells that have been treated before implantation and either seeded into the scaffold (cell-seeded scaffold method) or used alone (stem cell approach) to induce the formation or regeneration of functional tissue.

• Cells in cell-seeded scaffolds might come from autologous, allogeneic, or heterologous sources (xenogeneic). The best option is autologous, eliminating the danger of rejection and the difficulties associated with immunosuppression.

2. Stem Cells:

• Because of their capacity to grow and divide into specific cell lines, stem cells are an appealing cell source for applications in tissue engineering that do not need autologous cell line development in vitro. Stem cells are distinguished by their capacity to self-renew and differentiate across many lineages.

What Are The Applications Of Tissue Engineering And Stem Cells In The Genitourinary Tract?

1. Treatment Of Acute Renal Failure:

• Several acute renal failure models have been developed to investigate the role of stem cells in the regeneration of acutely injured renal tissue. Bone marrow stem cells (BMSC) were shown to be effective in preventing cisplatin-induced kidney impairment. In contrast, it did not affect epithelial integrity repair in a severe ischemic renal damage model.

• Yet, in vitro and in vivo, injured kidney tissue might drive rat and human bone marrow stem cells (BMSC) to develop into renal tubular epithelial-like cells. Exogenous human BMSC can selectively home to affected areas and repair rat acute renal failure.

2. Treatment Of Chronic Renal Failure:

• The preliminary findings of utilizing SC in rats' chronic renal failure model were encouraging. SC might avoid peritubular capillaries loss, lower indicators of renal fibrosis, and attenuate the course of proteinuria.

• Moreover, SC may have a role in moderating the inflammatory response before the early phase of a chronic renal injury, which may contribute to reduced fibrosis in chronic renal failure.

3. Construction Of Kidney Tissue:

• Recreating a functioning renal unit is an effective approach to treating renal failure. Lanza et al. created functional immune-compatible renal tissues using renal cells from an early-stage cloned cow fetus.

• The cloned renal cells were grown in vitro, placed onto renal units, and transplanted back into the nuclear donor animal without being destroyed by the immune system. The cells formed glomerulus and tubule-like structures capable of secreting harmful waste products via a urine-like fluid from metabolic processes.

• Moreover, Yokoo et al. demonstrated that a mixture of whole-embryo culture and organ culture induces exogenous human mesenchymal stem cells (MSC) to distinguish and add to complex functional structures of the new kidney.

4. Ureter:

• Ureteral defects are often surgical problems. Efforts to repair ureteral deficiencies with TE require more research. Osman et al. studied the replacement of a three-centimeter segment defect in an animal model with a tube of an acellular matrix of the same length and breadth produced from canine ureters following decellularization procedures.

• By the end of the investigation, the researchers reported considerable shrinkage, severe narrowing of the lumen to complete blockage, and widespread fibrosis. They concluded that the acellular matrix could not repair a lengthy stricture ureter.

• A two-centimeter-long and a circumference of one-half ureteral lesion was bridged with an on-lay patch of swine small intestine submucosa allograft. This approach has caused ureteral regeneration while preserving renal function.

5. Bladder:

• Numerous efforts have been made to discover alternate methods of regenerating the bladder to prevent the consequences of urinary-intestinal diversion, including urolithiasis, metabolic abnormalities, excessive mucus production, and malignant illness.

• Bladder augmentation with acellular matrices can work in small animal models, but it frequently fails in bigger species like dogs and pigs. Moreover, providing growth agents to the acellular matrix may result in effective mouse bladder regeneration. Moreover, the chitosan-treated matrix increased nerve tissue regeneration and matrix characteristics.

• Several tests were executed to distinguish stem cells into urothelium or smooth muscle cell components. A characterized population of bone marrow mesenchymal stem cells (BM-MSC) and endothelial progenitor cells display contractile and vascular markers comparable to bladder wall components, making them suitable for bladder wall regeneration.

• Current efforts are being made to identify additional sources of cells for bladder regeneration. It is anticipated that epithelial and dermal multipotent stem cell populations inside hair follicles might open new avenues for urinary bladder tissue engineering. Additionally, stem cells produced from urine might be a novel and alternate source of bladder wall rejuvenation.

6. Urinary Incontinence:

• Tissue engineering methods include infusing stem cells into the rhabdosphincter to facilitate regeneration of the injured sphincter components or to use tissue engineering procedures to create suburethral slings. Progress has been obtained in both human and animal studies.

• In a stress urinary incontinence rat model, Kwon et al. investigated the impact of muscle-derived progenitor cells versus fibroblast injection. Both elevated the leak point pressure, but only muscle-derived cells considerably improved urethral muscle strip contractility.

Conclusion:

Regenerative medicine can assist in curing a variety of urological problems. Urological therapy techniques are evolving, and a new method is being developed to benefit patients and urologists. Although animal models are evolving and exhibiting favorable outcomes, more attention should be assigned to safety before large-scale human studies are yet to be explored.